JNJ

Johnson JohnsonB

NYSE / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Curated Events

Active

Recent Headlines

New

Curated events

Materiality

Source

External coverage

Decided

2026-06-17

J&J Is Focused on Fighting Cancer, Not Obesity Drugs, CEO Says

J&J's CEO said the company has no plans to enter obesity drugs and will stay focused on areas like cancer, a modest negative for J&J's obesity-optionality narrative and a modest positive for incumbent obesity leaders such as Eli Lilly via reduced future competitive pressure.

View event details

Sentiment decomposition

+65.2

30-day score

Company-55%

Macro-30%

Pulse-15%

Weekly research-10-day

Company, Macro, and Pulse form the existing 30-day artifact blend. Weekly research is tracked separately for 10 days and can contribute at most 10% of the sentiment pillar when live mode is enabled.

Recent headlines

No supplemental ticker headlines stored yet

We are still collecting relevant articles for JNJ. Curated events highlight the most material developments impacting this ticker right now.

Check curated events Open full news archive

As of 2026-05-15 • Updated scheduledSource: News desk